Actavis announced Monday that it will buy its pharmaceutical peer Allergan in a $66 billion deal that may finally thwart efforts by Valeant Pharmaceuticals to acquire the Botox manufacturer through a ...

“We sit in the low 60s in terms of Botox share, and that's a clear leadership position by a large margin in the U.S.,” AbbVie COO Jeff Stewart said on the company’s most recent earnings call on Oct.

When Valeant Pharmaceuticals International Inc. (NYSE: VRX) and activist investor Bill Ackman made an unsolicited $46 billion bid to purchase Botox maker Allergan Inc. (NYSE: AGN) last week, investors ...

Plus, everything you need to know about the needle-free alternatives.

As with all medications, the cost of Botox can vary. Factors that may affect the price you’ll pay include: your treatment plan the condition Botox is being used to treat your insurance coverage the ...

Botox, the pharmaceutical drug best known for smoothing out wrinkles, took more than a decade to reach its potential. On Tuesday, pharmaceutical giant AbbVie said it's acquiring Allergan, the company ...

Actavis said it would pay $66 billion in cash and stock for in a deal that appears to have thwarted a hostile takeover of the Botox maker. David Benoit joins MoneyBeat. Photo: AP. Two years ago, ...